Signs and symptoms
Genes
Methods
Disclaimer
About us
Publications
Contact us
Patients
Users
Database
Login
Overview of included studies for DYT-TOR1A:
Click here for summary of patients' characteristics
Click here for summary of genetic findings
Click here to show world map of all countries
Filter for
all included patients
index patients only
AAO < 50 (adjustable)
AAO >= 50 (adjustable)
females only
males only
homozygous only
heterozygous only
compound heterozygous only
homozygous and compound heterozygous
carrying
definitely pathogenic mutations
probably pathogenic mutations
possibly pathogenic mutations
c.354dupT
c.385G>A
c.40_45delGCGCCG
c.488C>T
c.613T>A
c.692T>A
c.823A>G
c.863G>A
c.907_909delGAG
c.934A>G
c.962C>T
Country
Argentina
Brazil
China
Egypt
France
Germany
India
Iran
Ireland
Israel
Italy
Japan
Poland
Russia
Serbia
South Korea
Spain
Taiwan
Turkey
United Kingdom
United States
Study
Study design
N cases
Ethnicities
Sex
(%
♂
)
Mean AAO (+/- SD)
Reported mutations
Kupsch, 2003
Case report/Case series
1
n.a.
n.a.
7
p.Glu303del
: het
Grundmann, 2003
Mutational screen
6
n.a.
67%
15(+/-13)
p.Glu303del
: het
Carmona, 2003
Mutational screen
5
n.a.
80%
9(+/-4)
p.Glu303del
: het
Anca, 2003
Other/Mixed
33
n.a.
58%
11(+/-4)
p.Glu303del
: het
Edwards, 2003
Other/Mixed
10
n.a.
60%
10(+/-4)
p.Glu303del
: het
Molloy, 2003
Other/Mixed
13
n.a.
n.a.
14(+/-11)
p.Glu303del
: het
Edwards, 2003
Case report/Case series
5
n.a.
40%
26(+/-19)
p.Glu303del
: het
Gatto, 2003
Case report/Case series
1
JA
0%
9
p.Glu303del
: het
Yianni, 2003
Case report/Case series
2
n.a.
50%
11(+/-6)
p.Glu303del
: het
Bressman, 2002
Mutational screen
10
n.a.
80%
26(+/-16)
p.Glu303del
: het
« First page
‹ Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next ›
Last page »
Show all studies on one page
© University of Lübeck. Last updated on
Dec. 2, 2020. Version: 3.5.95
MDSGene works best with JavaScript enabled. Please follow
these instructions
to activate JavaScript in your web browser.
MDSGene works best with JavaScript enabled. Please follow
these instructions
to activate JavaScript in your web browser.